Creo Addition
Payments companies reported to CMS as associated with Creo Addition. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Creo Addition, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Creo Addition
These are the largest totals companies reported as associated with Creo Addition. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joseph Obrien | Bethesda, MD | Orthopaedic Surgery of The Spine | $50,578.43 |
| Anthony Cucchi | Orlando, FL | Orthopaedic Surgery of The Spine | $35,368.96 |
| Ivan Cheng | Kyle, TX | Orthopaedic Surgery of The Spine | $35,368.96 |
| Dilip Sengupta | Mansfield, TX | Orthopaedic Surgery | $35,365.74 |
| Domagoj Coric | Charlotte, NC | Neurological Surgery | $35,363.26 |
| Michele Johnson | Atlanta, GA | Neurological Surgery | $801.55 |
| Brian Park | Columbus, OH | Neurological Surgery | $336.53 |
| James Mooney | Richmond, VA | Neurological Surgery | $336.53 |
| Michael Wang | Miami, FL | Neurological Surgery | $336.52 |
| Christopher Battista | Bloomington, MN | Emergency Medicine | $254.00 |
Prescribed Creo Addition?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.